Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 per share
-
Shares outstanding
-
162M
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
13.2M
-
Shares change
-
+6.5M
-
Total reported value, excl. options
-
$179M
-
Value change
-
+$88.8M
-
Put/Call ratio
-
0.98
-
Number of buys
-
84
-
Number of sells
-
-13
-
Price
-
$13.58
Significant Holders of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) as of Q1 2020
131 filings reported holding NVAX - NOVAVAX INC - Common Stock, Par Value $0.01 per share as of Q1 2020.
NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.2M shares
of 162M outstanding shares and own 8.11% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.75M shares), VANGUARD GROUP INC (2.06M shares), FRANKLIN RESOURCES INC (1.73M shares), MILLENNIUM MANAGEMENT LLC (631K shares), GEODE CAPITAL MANAGEMENT, LLC (616K shares), STATE STREET CORP (580K shares), Invesco Ltd. (523K shares), MORGAN STANLEY (436K shares), NORTHERN TRUST CORP (435K shares), and JPMORGAN CHASE & CO (434K shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.